Luo Allison 4
4 · Prometheus Biosciences, Inc. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Luo Allison
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-08+4,500→ 4,500 total(indirect: By Spouse)Exercise: $25.45Exp: 2031-09-07→ Common Stock (4,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in 12 equal monthly installments, commencing on September 1, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.